Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Venkatramana Industries is a specialized pharmaceutical company headquartered in Hyderabad, India, primarily engaged in the manufacture of Active Pharmaceutical Ingredients (APIs) and intermediates. The company has established a significant presence in the metabolic and cardiovascular therapeutic segments, producing high-demand bulk drugs such as Metformin Hydrochloride and Gliclazide. Operating with a focus on quality and regulatory compliance, Venkatramana Industries supplies essential chemical components to pharmaceutical formulation companies both domestically and internationally. Their manufacturing infrastructure is designed to support large-scale production while maintaining stringent Good Manufacturing Practice (GMP) standards. The firm plays a critical role in the global pharmaceutical supply chain by providing cost-effective raw materials for chronic disease management. Venkatramana Industries continues to expand its product portfolio to include a wider range of antidiabetic and antihypertensive agents.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Venkatramana Industries.